ME Therapeutics Holdings Statistics

Total Valuation

CSE:METX has a market cap or net worth of CAD 119.90 million. The enterprise value is 118.57 million.

Market Cap	119.90M
Enterprise Value	118.57M

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:METX has 30.05 million shares outstanding. The number of shares has increased by 14.17% in one year.

Current Share Class	30.05M
Shares Outstanding	30.05M
Shares Change (YoY)	+14.17%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	55.01%
Owned by Institutions (%)	n/a
Float	13.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	79.77
P/TBV Ratio	79.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-99.37
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-109.94

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.05.

Current Ratio	6.12
Quick Ratio	5.99
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-100.30

Financial Efficiency

Return on equity (ROE) is -80.11% and return on invested capital (ROIC) is -52.27%.

Return on Equity (ROE)	-80.11%
Return on Assets (ROA)	-48.35%
Return on Invested Capital (ROIC)	-52.27%
Return on Capital Employed (ROCE)	-84.25%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.25% in the last 52 weeks. The beta is -0.68, so CSE:METX's price volatility has been lower than the market average.

Beta (5Y)	-0.68
52-Week Price Change	-0.25%
50-Day Moving Average	4.65
200-Day Moving Average	5.39
Relative Strength Index (RSI)	47.55
Average Volume (20 Days)	1,174

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.28M
Pretax Income	-1.19M
Net Income	-1.19M
EBITDA	-1.24M
EBIT	-1.28M
Earnings Per Share (EPS)	-0.04

Full Income Statement

Balance Sheet

The company has 1.40 million in cash and 71,660 in debt, giving a net cash position of 1.33 million or 0.04 per share.

Cash & Cash Equivalents	1.40M
Total Debt	71,660
Net Cash	1.33M
Net Cash Per Share	0.04
Equity (Book Value)	1.50M
Book Value Per Share	0.05
Working Capital	1.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -862,347 and capital expenditures -216,153, giving a free cash flow of -1.08 million.

Operating Cash Flow	-862,347
Capital Expenditures	-216,153
Free Cash Flow	-1.08M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:METX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.17%
Shareholder Yield	-14.17%
Earnings Yield	-1.00%
FCF Yield	-0.90%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1